FDA Approves Teva Pharmaceutical Industries Limited Drug as First OTC Morning After Pill, Lifts Age Limit

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

The U.S. Food and Drug Administration on Thursday expanded its approval of the so-called "morning after" contraceptive pill to include all women of child-bearing age to comply with an order from a U.S. District court. The FDA said the Plan B One-Step emergency contraceptive, which is sold by Teva Pharmaceutical Industries, would be made available as an over-the-counter (OTC) product without age or point-of-sale restrictions. Plan B One-Step is a single dose pill intended to reduce the chance of pregnancy following unprotected sex or suspected contraceptive failure, such as a broken condom.

Help employers find you! Check out all the jobs and post your resume.

Back to news